Multi-Center Phase II Study on Efficacy of High-Slip Skin Care Pad for Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Renal Cell Carcinoma

Phase 2

• Conditions: Renal cell carcinoma

• Registration Number: JPRN-UMIN000002016
• Lead Sponsor: Japanese Society of Renal Cancer (JSRC)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-05-29
• Study Completion: 2012-04-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients undergoing combination therapy with cytokine therapy, chemotherapy, or molecularly targeted therapy 2) Patients who have used other molecularly targeted drug therapy 3) Patients in whom the underlying disease is a generalized dermatological disease 4) Patients with Grade 2 or higher HFSR on the hands 5) Patients with Grade 3 or higher adverse events other than HFSR 6) Patients with previously confirmed sorafenib-induced HFSR 7) Patients determined to be unsuitable by investigators 8) Patients who may otherwise compromise patient safety in the conduct of the trial or who may compromise protocol compliance

Study & Design

• Study Type: Interventional
• Study Design: Not specified